Hemodynamic Correction and Early Detection of Tubulointerstitial Fibrosis Prevent Disease Progression in Chronic Kidney Disease

References

• Futrakul P., Yenrudi S., Futrakul N., Sensirivatana R., Kingwatanakul P., Jungthirapanich J., Cherdkiadtikul T., Laohapaibul A., Watana D., Singkhwa V., Futrakul S., Pongsin P. Tubular function and tubulointerstitial disease. Am. J. Kidney Dis. 1999; 33: 886–891, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Futrakul N., Pochanugool C., Sitprija V., Futrakul P., Yenrudi S., Sensirivatana R., Watana D., Poshyachinda M. Renal dysfunctions in glomerulonephropathy with rapidly declined renal failure. Ren. Fail. 1996; 18: 557–565, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Futrakul N., Yenrudi S., Sensirivatana R., Watana D., Laohapaibul A., Watanapenphaibul K., Kingwatanakul P., Futrakul P., Futrakul S. Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren. Fail. 2000; 22: 329–335, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Scandling J. S., Black V. M., Deen W. M., Meyers B. D. Glomerular permselectivity in healthy and nephrotic humans. Adv. Nephrol. 1992; 21: 159–176
   PubMedGoogle Scholar
• Futrakul P., Poshyachinda M., Mitrakul C. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study. Clin. Nephrol. 1978; 10: 180–186, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Futrakul P., Poshyachinda M., Yenrudi S., Saleekul P., Sensirivatana R., Futrakul N., Apaiwong S., Pochanugool C., Thamaree S., Buranasiri K., Watana D., Kingwatanakul P., Panichpun S., Kwoepaitoon S., Tiromparin C. Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: therapeutic benefit with vasodilators. J. Med. Assos. Thail. 1992; 75: 375–385
   PubMedGoogle Scholar
• Campbell R., Sangalli F., Perticucci E., Aros C., Viscarra C., Perna A., Remuzzi A., Bertocchi F., Fagiani L., Remuzzi G., Ruggenenti P. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int. 2003; 63: 1094–1103, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kriz W., Elger M., Nagata M., Kretzler M., Uiker S., Koeppen‐Hazemann I., Tenschert S., Lemley K. V. The role of podocytes in the development of gloemrulosclerosis. Kidney Int. 1994; 45(suppl. 45)64–72
   Google Scholar
• Fogo A. Nephrotic syndrome: molecular and genetic basis. Nephron 2000; 85: 8–13, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rennke H. G. How does glomerular epithelial injury contribute to progressive glomerular damage?. Kidney Int. 1994; 45(suppl. 45)58–63
   PubMedGoogle Scholar
• Futrakul N., Siriviriyakul P., Panichakul T., Butthep P., Patumraj S., Futrakul. Glomerular endothelial cytotoxicity and dysfunction and immunocirculatory defect in nephrosis with focal segmental glomerulosclerosis. Clin. Hemorheol. Microcirc. 2003; 29: 469–473, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ruiz‐Ortega M., Egido J. Angiotensin II modulates cell growth‐related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 1997; 52: 1497–1510
   PubMed Web of Science ®Google Scholar
• Bottinger E. P., Bitzer M. TGF‐B signaling in renal disease. J. Am. Soc. Nephrol. 2002; 13: 260–269, [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Fogo A. B. The role of angiotensin II and plasminogen activator inhibitor‐1 in progressive glomerulosclerosis. Am. J. Kidney Dis. 2000; 35: 179–188, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Wei Z., Costa K., Al‐Medhi A. B., Dodia C., Muzykantor V., Fisher A. B. Simulated ischemia in flow‐adapted endothelial cells lead to generation of reactive oxygen species and cell signaling. Circ. Res. 1999; 85: 682–689, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Komine N., Khang S., Wead L. M., Blantz R. C., Gubbar F. B. Effect of combining an ACE inhibitor and angiotensin II receptor blocker on plasma and kidney tissue giotensin II levels. Am. J. Kidney Dis. 2002; 39: 159–164, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Futrakul N., Tohsukhowong P., Patumraj S., Siriviriyakul P., Tipprukmas N., Futrakul P. Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides. Ren. Fail. 2003; 25: 839–844, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Futrakul N., Tosukhowong P., Valyapongpichit Y., Tipprukmas N., Futrakul P., Patumraj S. Oxidative stress and hemodynamic maladjustment in chronic renal disease: a therapeutic implication. Ren. Fail. 2002; 24: 433–445, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar